Silicosis and Silicotuberculosis Among Small Scale Gemstone Miners in Northern Tanzania
SilicoTB
1 other identifier
observational
1,400
1 country
1
Brief Summary
Artisanal, small-scale mining (ASM) is a large and essential component of the world's economy. Despite attendant risks, there is little research into risks to the health of artisanal miners. The tanzanite gemstone is mined exclusively in Northern Tanzania, in deep shafts using ASM techniques. There is concerning evidence that the burden of silicosis and tuberculosis (TB) amongst miners is high. In addition to miners' personal risks, there is concern that a high rate of silicotuberculosis may hamper community control of TB. Our primary aim is to measure the rate of silicosis progression among tanzanite miners. Our secondary aims include measuring the prevalence of TB among miners, describing TB transmission patterns in miners and the community, and assessing rates of 'catastrophic' economic loss amongst miners. To do this, the investigators propose two studies. First, the investigators will establish a prospective cohort of 410 small scale tanzanite miners and record symptoms, respiratory function including spirometry, chest radiography, and prevalence of TB and Human Immunodeficiency Virus (HIV) infection over an 18-month period. Second, the investigators will utilize an ongoing community-based TB screening program to perform a cross-sectional survey of TB prevalence among miners and community members. To assess TB transmission, the investigators will collect epidemiological data and perform whole genome sequencing (WGS) on positive Mycobacterium tuberculosis (MTb) culture samples. Given the lack of research and large global ASM workforce, 1 million of whom are in Tanzania, the results of this study will assist in the development and introduction of interventions to reduce the risks to respiratory health of artisanal mining in Tanzania and elsewhere; and provide ample scope for future work.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2024
CompletedFirst Submitted
Initial submission to the registry
May 3, 2024
CompletedFirst Posted
Study publicly available on registry
May 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMay 16, 2024
May 1, 2024
1.6 years
May 3, 2024
May 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in chest radiography
Rate of change of the ILO classification of pneumoconioses among cohort participants
18-months
Secondary Outcomes (6)
Silicosis prevalence at baseline
Baseline
TB prevalence at baseline
Baseline
Clustering of TB cases
18-months
Measurement of 'catastrophic' economic loss
18-months
Use of C-reactive protein as a screening aid for TB
Baseline
- +1 more secondary outcomes
Study Arms (2)
Cross-sectional study
In the cross-sectional study group, we will enroll approximately 1400 miners and community members from an ongoing community-based, screening program, which is led by Kibong'oto Infectious Diseases Hospital (KIDH), and from incident TB cases from the local Mererani health centre and KIDH clinic.
Cohort group
We will enroll the prospective cohort group of 410 small-scale tanzanite miners from within the cross-sectional study group (nested). They will be sampled from specific mines chosen by a random stratified sample of mines.
Interventions
Eligibility Criteria
Tanzanite mines are near Mererani, Simanjaro District, Northern Tanzania. The district population is 178,683, with 13,450 in Mererani. Recent data suggests Mererani's population is around 18,300 due to regional growth. About 100 active licenses exist, with each mine employing 70 to 90 miners, totaling around 9,000 miners; earlier estimates were higher at 15,000. Healthcare is provided by Kibongo'oto Infectious Diseases Hospital, 60 km away, with one other clinic offering TB services. Recruitment for our survey is from a TB screening program, offering free CXR and Xpert tests via a mobile clinic rotating. We plan to include 5-10 mines in the study, focusing on diverse roles and exposures.
You may qualify if:
- Age \> 18 years
- Ability to provide informed consent
- Miner or community member (defined as all individuals not directly involved in mining)
- HIV positive and negative individuals
- Age \> 18 years
- Ability to provide informed consent
- Current miner in an artisanal, small-scale tanzanite mine that is part of this study
- Male
- Mine exposure starting \<10 years ago
- HIV positive and negative individuals
You may not qualify if:
- \- Plans to move away from area in next 18 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kibong'oto Infectious Diseases Hospital
Sanya Juu, Kilimanjaro, PO Box, Tanzania
Related Publications (6)
Howlett P, Mousa H, Said B, Mbuya A, Kon OM, Mpagama S, Feary J. Silicosis, tuberculosis and silica exposure among artisanal and small-scale miners: A systematic review and modelling paper. PLOS Glob Public Health. 2023 Sep 21;3(9):e0002085. doi: 10.1371/journal.pgph.0002085. eCollection 2023.
PMID: 37733799BACKGROUNDDennis E, Mussa H, Sanga MP, Howlett P, Nyakunga G. Silicosis and silicotuberculosis among respiratory hospital admissions: A cross-sectional survey in northern Tanzania. Afr J Thorac Crit Care Med. 2023 Sep 19;29(3):10.7196/AJTCCM.2023.v29i3.269. doi: 10.7196/AJTCCM.2023.v29i3.269. eCollection 2023.
PMID: 37970570BACKGROUNDMbuya AW, Mboya IB, Semvua HH, Msuya SE, Howlett PJ, Mamuya SH. Concentrations of respirable crystalline silica and radon among tanzanite mining communities in Mererani, Tanzania. Ann Work Expo Health. 2024 Jan 8;68(1):48-57. doi: 10.1093/annweh/wxad062.
PMID: 37824745BACKGROUNDRees D, Murray J. Silica, silicosis and tuberculosis. Int J Tuberc Lung Dis. 2007 May;11(5):474-84.
PMID: 17439668BACKGROUNDEhrlich R, Murray J, Rees D. Subradiological silicosis. Am J Ind Med. 2018 Nov;61(11):877-885. doi: 10.1002/ajim.22909. Epub 2018 Sep 21.
PMID: 30239033BACKGROUNDEhrlich R, Akugizibwe P, Siegfried N, Rees D. The association between silica exposure, silicosis and tuberculosis: a systematic review and meta-analysis. BMC Public Health. 2021 May 20;21(1):953. doi: 10.1186/s12889-021-10711-1.
PMID: 34016067BACKGROUND
Biospecimen
Sputum samples for MTb culture and MTb DNA extraction Whole blood samples for haematology Serum samples for biochemistry and serum save
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor Clinical Research Fellow
Study Record Dates
First Submitted
May 3, 2024
First Posted
May 8, 2024
Study Start
March 11, 2024
Primary Completion
October 1, 2025
Study Completion
December 1, 2025
Last Updated
May 16, 2024
Record last verified: 2024-05